Crew health monitoring is the structured collection and interpretation of physiological, clinical, behavioural and environmental information used to protect people before, during and after spaceflight. It can combine scheduled medical examinations, wearable sensors, imaging, biological samples, exercise and cognitive measures, radiation dosimetry, and cabin air or water data.1

Measurements and decisions

International Space Station research has used watches, headbands, vests and other wearables to study sleep, activity, body temperature, cardiovascular signals and breathing. Crew-worn instruments have also measured local carbon dioxide and radiation exposure.2 Biological sampling adds blood, urine, saliva, faecal and microbiome measurements, while ultrasound and other compact imaging can examine internal tissues.3

These streams serve different purposes. A research sensor may reveal population-level adaptation without being certified to diagnose an individual medical condition. Operational monitoring can identify a trend, trigger a clinical review or assess a countermeasure, but measurement alone does not provide diagnosis or treatment. Sensor accuracy, baseline variation, false alarms, data privacy, crew time and the ability to act on a result all affect its value.

Current ISS practice uses several discrete devices and retains substantial support from ground teams and terrestrial laboratories. Missions beyond low Earth orbit will face communication delays, smaller crews, limited consumables and fewer opportunities to return samples or evacuate a patient. NASA is therefore evaluating compact systems for real-time monitoring, medical imaging and point-of-care analysis of blood, urine and saliva.1 These are development priorities; their inclusion on a programme page does not establish operational deep-space capability.

Integrated and wearable systems

The UK-developed Tempus Pro combines vital-sign measurements, telemedicine communications, procedure support and imaging. ESA has used it to monitor astronauts after landing and tested it at Antarctic bases, while NASA has evaluated its usability in a hypobaric ground analogue.45 Those uses demonstrate an operational post-landing role and analogue experience, but not routine autonomous diagnosis during a lunar or Mars mission.

ESA’s PhysioTool experiment used synchronised mobile sensors aboard the ISS in 2026 to measure cardiovascular, respiratory, temperature, oxygenation and sleep variables alongside cognitive tasks.6 The source describes an active experiment and its intended contribution, rather than final results.

UK research also examines sensor-integrated garments and soft robotic systems that might combine monitoring with loading or exercise. A 2026 Imperial College London-affiliated review describes their potential to reduce the mass and space demanded by present countermeasures.7 These designs remain research proposals or developing technologies unless a separate source documents flight qualification and operational use.

References

Footnotes

  1. NASA, Exploration Medical Technologies. ↩ ↩2

  2. NASA, Wearable Tech for Space Station Research. ↩

  3. NASA Human Research Program, Sample collection and portable systems. ↩

  4. NASA, Multifunctional Integrated Medical Devices. ↩

  5. European Space Agency, From Antarctica to space: telemedicine at the limit. ↩

  6. European Space Agency, PhysioTool: Understanding how the body and mind adapt to microgravity. ↩

  7. Khan et al., Space Physiology and Technology: Adaptations, Countermeasures, and Opportunities for Wearable Systems (2026). ↩